Literature DB >> 9463378

The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors.

R S Lo1, Y G Chen, Y Shi, N P Pavletich, J Massagué.   

Abstract

Signal transduction specificity in the transforming growth factor-beta (TGF-beta) system is determined by ligand activation of a receptor complex which then recruits and phosphorylates a subset of SMAD proteins including Smads 1 and 2. These then associate with Smad4 and move into the nucleus where they regulate transcription. We have identified a discrete surface structure in Smads 1 and 2 that mediates and specifies their receptor interactions. This structure is the L3 loop, a 17 amino acid region that protrudes from the core of the conserved SMAD C-terminal domain. The L3 loop sequence is invariant among TGF-beta- and bone morphogenetic protein (BMP)-activated SMADS, but differs at two positions between these two groups. Swapping these two amino acids in Smads 1 and 2 induces a gain or loss, respectively, in their ability to associate with the TGF-beta receptor complex and causes a switch in the phosphorylation of Smads 1 and 2 by the BMP and TGF-beta receptors, respectively. A full switch in phosphorylation and activation of Smads 1 and 2 is obtained by swapping both these two amino acids and four amino acids near the C-terminal receptor phosphorylation sites. These studies identify the L3 loop as a determinant of specific SMAD-receptor interactions, and indicate that the L3 loop, together with the C-terminal tail, specifies SMAD activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463378      PMCID: PMC1170449          DOI: 10.1093/emboj/17.4.996

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.

Authors:  J M Graff; A Bansal; D A Melton
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

2.  Smad6 inhibits signalling by the TGF-beta superfamily.

Authors:  T Imamura; M Takase; A Nishihara; E Oeda; J Hanai; M Kawabata; K Miyazono
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

3.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium.

Authors:  J N Topper; J Cai; Y Qiu; K R Anderson; Y Y Xu; J D Deeds; R Feeley; C J Gimeno; E A Woolf; O Tayber; G G Mays; B A Sampson; F J Schoen; M A Gimbrone; D Falb
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

Authors:  F T Boyd; J Massagué
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

5.  A structural basis for mutational inactivation of the tumour suppressor Smad4.

Authors:  Y Shi; A Hata; R S Lo; J Massagué; N P Pavletich
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

6.  Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

Authors:  G Lagna; A Hata; A Hemmati-Brivanlou; J Massagué
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

Review 7.  Transcriptional regulation by extracellular signals: mechanisms and specificity.

Authors:  C S Hill; R Treisman
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  Mechanism of TGFbeta receptor inhibition by FKBP12.

Authors:  Y G Chen; F Liu; J Massague
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

9.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.

Authors:  A Hata; G Lagna; J Massagué; A Hemmati-Brivanlou
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

10.  Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor.

Authors:  G H Thomsen
Journal:  Development       Date:  1996-08       Impact factor: 6.868

View more
  53 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.

Authors:  Yuto Kamiya; Kohei Miyazono; Keiji Miyazawa
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

Review 3.  Structural determinants of Smad function in TGF-β signaling.

Authors:  Maria J Macias; Pau Martin-Malpartida; Joan Massagué
Journal:  Trends Biochem Sci       Date:  2015-04-29       Impact factor: 13.807

4.  Determinants of specificity in TGF-beta signal transduction.

Authors:  Y G Chen; A Hata; R S Lo; D Wotton; Y Shi; N Pavletich; J Massagué
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

Review 5.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

6.  A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein.

Authors:  Qian Tang; Cory M Staub; Guofeng Gao; Qunyan Jin; Zhengke Wang; Wei Ding; Rosemarie E Aurigemma; Kathleen M Mulder
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

7.  Structure of Drosophila Mad MH2 domain.

Authors:  Rui Hao; Lei Chen; Jia-Wei Wu; Zhi-Xin Wang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

Review 8.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17

Review 9.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

10.  Human SMAD4 is phosphorylated at Thr9 and Ser138 by interacting with NLK.

Authors:  Yan Shi; Kan Ye; Huiling Wu; Yixing Sun; Huili Shi; Keke Huo
Journal:  Mol Cell Biochem       Date:  2009-08-19       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.